It's quite simple that if they were to launch, there would have...

It's quite simple that if they were to launch, there would have been an ASX announcement as it is a materially significant event. You are just reading into things they say and pushing a line that isn't supported by evidence. Playing semantics because you cant say you were wrong. As pointed out, they never said they would have FDA approval, but according to you and your posts, they would.
The way forward now is obvious.
1. Cash Raise by the end of the quarter. How well that is supported will determine whether they get to the point of launching Gen 4.
2. If they can show that the current product is increasing in sales, not only will this help with the bottom line, but it will show investors that there is a market and, in turn, help with a cash raise.
3. The 5000 POS was always suspect. So many posters on here pointed out they didn't have the cash to stock. This pivot by Justin to 1000 is not unexpected except by maybe you who harped on 5000 units etc. The problem with the 1000 POS model is still the same one they had with 5000 or with 500 best buys. They need cash to advertise. They showed they could use advertising to grow sales with max. Unfortunately, we ended up back at point 1.